| Bioactivity | (Rac)-Aurora A/PKC-IN-1 (Compund 2e) is an orally active Aurora A and PKC (α, β1, β2 and θ) kinase inhibitor. (Rac)-Aurora A/PKC-IN-1 has antiproliferative activity in breast cancer cells in vitro and antimetastatic activity in vivo[1]. |
| CAS | 2143100-98-3 |
| Formula | C16H14N6OSe2 |
| Molar Mass | 464.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bijian K, et al. Novel Aurora A and Protein Kinase C (α, β1, β2, and θ) Multitarget Inhibitors: Impact of Selenium Atoms on the Potency and Selectivity. J Med Chem. 2022 Feb 24;65(4):3134-3150. |
(Rac)-Aurora A/PKC-IN-1
CAS: 2143100-98-3 F: C16H14N6OSe2 W: 464.24
(Rac)-Aurora A/PKC-IN-1 (Compund 2e) is an orally active Aurora A and PKC (α, β1, β2 and θ) kinase inhibitor. (Rac)-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.